Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
Latest Orthopedics News
Amedica, Kyocera ink deal for silicon nitride medical devices
Amedica Corp. entered into an agreement with Kyocera Industrial Ceramics Corp. to manufacture Amedica’s silicon nitride biomaterial at Kyocera’s Vancouver, Wash., facility.
The FDA-cleared silicon nitride has the potential to promote bone growth defend against infection. Devices made from silicon nitride are semi-radiolucent with clearly visible boundaries, enabling an exact view of intra-operative placement and postoperative fusion assessment via common imaging modalities, according to a press release.
Did patients draw the short stick in $2.5B J&J metal hip settlement? | MassDevice.com On Call
MASSDEVICE ON CALL — When Johnson & Johnson (NYSE:JNJ) agreed to a $2.5 billion settlement to close some 8,000 cases over its metal-on-metal hip implants, about 1/3 of that money went to the lawyers and legal teams representing the cases.
Johnson & Johnson confirms $2.5B hip lawsuit settlement, consumers group wants more
FLASH: Johnson & Johnson to settle DePuy ASR lawsuits for $2.5B
The Wall Street Journal is reporting that Johnson & Johnson (NYSE:JNJ) agreed to pay at least $2.5 billion to settle thousands of U.S. product liability lawsuits filed over its recalled DePuy ASR metal-on-metal hip implant.
Wright Medical closes $80M Biotech International buyout
Wright Medical (NSDQ:WMGI) said the $80 million buyout of French orthopedic implant maker Biotech International it announced last month is on the books and could push its full-year sales to the higher end of its guidance.
InVivo surges 56% on news of impending U.S. trial, search for strategic partnerships
FDA takes another look at ‘spinal spheres’ and stair-climbing wheelchairs
FDA regulators plan to meet next month to review a handful of medical devices and possibly recommend reclassification for spinal fusion ‘spheres’ and both stair-climbing and mechanical wheelchairs.
The agency noted in the Federal Register that its Orthopaedic & Rehabilitation Devices Panel will meet December 12 to review the technologies based on new reviews of their safety and effectiveness.
Zimmer and OrthoSensor team up to co-market sensor-assisted knee surgery
Orthopedics giant Zimmer (NYSE:ZMH) and OrthoSensor signed a co-marketing agreement pairing Zimmer’s NexGen knee systems with OrthoSensor’s Verasense technology.
Federal appeals court upholds Spinal Kinetics win over Synthes
Biomet signs Euro distribution deal with Titan Spine
Biomet signed a European distribution deal for Titan Spine’s Endoskeleton interbody fusion devices, beginning in Germany and spreading through the E.U., the companies announced.